BRIGHTCOVE (BCOV)
US10921T1016 - Common Stock
Overall BCOV gets a fundamental rating of 3 out of 10. We evaluated BCOV against 85 industry peers in the IT Services industry. BCOV scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BCOV is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year BCOV was profitable.
BCOV had a positive operating cash flow in the past year.
In the past 5 years BCOV reported 4 times negative net income.
Each year in the past 5 years BCOV had a positive operating cash flow.
1.2 Ratios
The Return On Assets of BCOV (-4.04%) is comparable to the rest of the industry.
With a Return On Equity value of -9.06%, BCOV perfoms like the industry average, outperforming 45.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.04% | ||
| ROE | -9.06% | ||
| ROIC | N/A |
ROA(3y)-4.02%
ROA(5y)-5.56%
ROE(3y)-9.19%
ROE(5y)-12.88%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of BCOV (61.36%) is better than 81.93% of its industry peers.
BCOV's Gross Margin has been stable in the last couple of years.
BCOV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 61.36% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.06%
GM growth 5Y0.65%
2. Health
2.1 Basic Checks
BCOV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BCOV has been increased compared to 1 year ago.
Compared to 5 years ago, BCOV has more shares outstanding
BCOV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
BCOV has an Altman-Z score of -0.47. This is a bad value and indicates that BCOV is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.47, BCOV is doing worse than 80.72% of the companies in the same industry.
BCOV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | -0.47 |
ROIC/WACCN/A
WACC9.55%
2.3 Liquidity
BCOV has a Current Ratio of 0.73. This is a bad value and indicates that BCOV is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of BCOV (0.73) is worse than 85.54% of its industry peers.
A Quick Ratio of 0.73 indicates that BCOV may have some problems paying its short term obligations.
BCOV's Quick ratio of 0.73 is on the low side compared to the rest of the industry. BCOV is outperformed by 85.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.73 | ||
| Quick Ratio | 0.73 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 172.73% over the past year.
Looking at the last year, BCOV shows a decrease in Revenue. The Revenue has decreased by -1.16% in the last year.
BCOV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.07% yearly.
EPS 1Y (TTM)172.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
Revenue 1Y (TTM)-1.16%
Revenue growth 3Y0.64%
Revenue growth 5Y4.07%
Sales Q2Q%-3.41%
3.2 Future
BCOV is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.92% yearly.
Based on estimates for the next years, BCOV will show a decrease in Revenue. The Revenue will decrease by -0.03% on average per year.
EPS Next Y-93.8%
EPS Next 2Y-5.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-2.1%
Revenue Next 2Y-0.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 26.75, BCOV can be considered very expensive at the moment.
BCOV's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of BCOV to the average of the S&P500 Index (30.20), we can say BCOV is valued inline with the index average.
The Forward Price/Earnings Ratio is negative for BCOV. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.75 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BCOV is valued a bit cheaper than 79.52% of the companies in the same industry.
61.45% of the companies in the same industry are cheaper than BCOV, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 991.02 | ||
| EV/EBITDA | 9.74 |
4.3 Compensation for Growth
A cheap valuation may be justified as BCOV's earnings are expected to decrease with -5.92% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.92%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for BCOV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BRIGHTCOVE
NASDAQ:BCOV (11/4/2024, 8:00:00 PM)
After market: 2.7 +0.56 (+26.17%)2.14
+0.07 (+3.38%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap96.13M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.75 | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.04% | ||
| ROE | -9.06% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 61.36% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.94
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.73 | ||
| Quick Ratio | 0.73 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)172.73%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-93.8%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-1.16%
Revenue growth 3Y0.64%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y